Allopurinol-Induced DRESS and Neosensitization to Thalidomide: Complex Management and Diagnosis in a Patient With Multiple Myeloma

F Vílchez-Sánchez; J M Busto Leis; E Sendagorta; E Ramírez; A Fiandor; T Bellón; T De Soto Álvarez; H Sánchez Ocando; R Heredia Revuelto; R Cabañas

doi:10.18176/jiaci.0776

Allopurinol-Induced DRESS and Neosensitization to Thalidomide: Complex Management and Diagnosis in a Patient With Multiple Myeloma

J Investig Allergol Clin Immunol. 2022 Oct 11;32(5):406-407. doi: 10.18176/jiaci.0776. Epub 2022 Jan 14.

Authors

F Vílchez-Sánchez^{1

2}, J M Busto Leis³, E Sendagorta^{3

4}, E Ramírez^{1

4

5}, A Fiandor^{1

2

4}, T Bellón^{1

4

6}, T De Soto Álvarez⁷, H Sánchez Ocando², R Heredia Revuelto², R Cabañas^{1

2

4

8}

Affiliations

¹ Institute for Health Research (IdiPAZ), Madrid, Spain.
² Allergy Department, La Paz University Hospital, Madrid, Spain.
³ Dermatology Department, La Paz University Hospital, Madrid, Spain.
⁴ PIELenRed Consortium.
⁵ Pharmacology Department La Paz University Hospital, Madrid, Spain.
⁶ Drug Hypersensitivity Laboratory, IdiPAZ, Madrid, Spain.
⁷ Hematology Department, La Paz University Hospital, Madrid, Spain.
⁸ Centro de Investigación en Red de Enfermedades Raras (CIBERER, U754).

PMID: 35029153
DOI: 10.18176/jiaci.0776

No abstract available

MeSH terms

Allopurinol / adverse effects
Drug Hypersensitivity Syndrome* / diagnosis
Drug Hypersensitivity Syndrome* / etiology
Humans
Multiple Myeloma* / diagnosis
Multiple Myeloma* / drug therapy
Thalidomide / adverse effects

Substances

Thalidomide
Allopurinol